Effect of Omega-3 LCPUFA Intervention on Learning, Cognition, Behaviour and Visual Processing.

April 5, 2017 updated by: Dr. Renate de Groot, Open University

Food2Learn: Effect of Omega-3 LCPUFA Intervention on Learning, Cognition, Behaviour and Visual Processing.

The brain is primarily developed in the third trimester of pregnancy, but continues maturing through the late twenties, especially the prefrontal cortex. Omega-3 long-chain polyunsaturated fatty acids (LCPUFA) are important structural components of neural cell membranes, influence membrane fluidity and signal transduction, and thus learning, cognition and behaviour. Levels of omega-3 LCPUFA have been found to be low in individuals with limitations in these complex brain functions. Previous studies suggested that such functions could be improved by increasing LCPUFA. The adolescent brain, however, has been largely neglected. This study investigates the effect of one-year daily omega-3 LCPUFA supplementation, in particular krill oil, in healthy 14-15 year old adolescents in lower general secondary education (MAVO/VMBO) on learning, cognition, and behaviour. The majority of the omega-3 PUFA in krill oil is incorporated into phospholipids, favouring tissue uptake of its omega-3 PUFA. In a double blind, randomised controlled trial, 300 adolescents preselected from a population of 700 adolescents with low omega-3 index (<5%) will receive daily omega-3 LCPUFA supplementation or matching placebo. The omega-3 LCPUFA dose will be adjusted individually to reach a target level of 8-11%. The effects on learning (academic achievement, objective cognitive performance), behaviour (mood, self-esteem, motivation, goal-orientation, absenteeism), and in a subsample cognitive processes, in particular perceptual processes measured by eye-tracking will be evaluated after 6, 12, and 24 months. This study will yield important insights in the effects of omega-3 LCPUFA supplementation, a safe intervention, on a large variety of complex brain functions.

Study Overview

Study Type

Interventional

Enrollment (Actual)

266

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Geldrop, Netherlands
        • Stabrecht College
      • Geleen, Netherlands
        • Graaf Huyn College
      • Gulpen, Netherlands
        • Scholengemeenschap Sophianum
      • Heerlen, Netherlands
        • Citaverde
      • Heerlen, Netherlands
        • Grotius College
      • Heerlen, Netherlands
        • Sintermeertencollege
      • Kerkrade, Netherlands
        • Beroepscollege Holz
      • Panningen, Netherlands
        • Bouwens van der Boijecollege
      • Sittard, Netherlands
        • DaCapo College
      • Valkenburg, Netherlands
        • Stella Maris College
      • Venlo, Netherlands
        • Colllege Den Hulster
    • Brabant
      • Breda, Brabant, Netherlands
        • De Nassau
      • Breda, Brabant, Netherlands
        • Graaf Engelbrecht
      • Breda, Brabant, Netherlands
        • Newman College
    • Gelderland
      • Nijmegen, Gelderland, Netherlands
        • Canisius College
    • Limburg
      • Roermond, Limburg, Netherlands
        • MAVO Roermond
    • Noord Brabant
      • Helmond, Noord Brabant, Netherlands
        • Dr.Knippenberg College

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 15 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy adolescents aged 14-15 years.
  • In lower general secondary education (MAVO/VMBO).

Exclusion Criteria:

  • Suffering from hemophilia (blood clotting disorder).
  • Allergic to (shell)fish.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Krill oil capsules

Capsules containing krill oil rich in omega-3 fatty acid's.

Dietary supplements (krill oil) are provided by Aker BioMarine Antarctic AS equalling almost the daily recommended amount of 450 mg of EPA/DHA intake per day.

Addendum 25-4-2016: In the Original protocol a dose adjustment after 3 months according to Omega-3 Index was to be executed. As no participant achieved the target Omega-3 Index the dosage was adjusted to 800mg DHA + EPA per day for all participants. The also led to the decision to increase the starting dosage of cohort II to 800mg DHA+ EPA.

1 year supplementation with Krill oil provided by Aker BioMarine Antarctic AS equalling almost the daily recommended amount of 450 mg of EPA/DHA intake per day.
Placebo Comparator: Placebo
Capsules containing a fatty acid mixture that reflects the fatty acid composition of the average European diet.
Capsules containing a fatty acid mixture that reflects the fatty acid composition of the average European diet.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognitive performance
Time Frame: 12 months
Neuropsychological tests covering seceral executive functions (LDST, D2, CST, Stroop, Digit Span).
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Eye tracking
Time Frame: 12 months
Two types of eye tracking parameters will be calculated, namely basic parameters and paragraph-related parameters. Basic parameters are number of blinks, number of fixations, total duration of fixations, average fixation duration, average dispersion of fixation positions, average saccadic amplitude, and average saccadic velocity. Moreover, we will calculate eye tracking measures per paragraph, namely time spent on each paragraph (number and duration of fixations), time elapsed until first looking at a paragraph, and amount of times going back to a paragraph (revisits).
12 months
Academic achievement
Time Frame: 12 months
Grade point average for Dutch, English and mathematics and standardized mathematics test scores (AMN).
12 months
Behaviour: absenteeism, motivation (MSLQ), Mood (CES-D), Self-esteem
Time Frame: 12 months
Absenteeism, motivation (MSLQ), Mood (CES-D), Self-esteem
12 months
Sleep duration and sleep quality
Time Frame: 12 months
Sleep duration measured using ActivPAL and diary, Sleep quality determined using the adolescent sleep wake scale (ASWS) and the adolescent sleep hygiene scale (ASHS).
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Renate de Groot, PhD, Open University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (Actual)

March 1, 2016

Study Completion (Actual)

August 1, 2016

Study Registration Dates

First Submitted

September 5, 2014

First Submitted That Met QC Criteria

September 12, 2014

First Posted (Estimate)

September 15, 2014

Study Record Updates

Last Update Posted (Actual)

April 6, 2017

Last Update Submitted That Met QC Criteria

April 5, 2017

Last Verified

April 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • Food2Learn
  • 13-T-115 (Other Identifier: METC Atrium-Orbis-Zuyd)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Function

Clinical Trials on Krill oil capsules

3
Subscribe